Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
3.010
-0.120 (-3.83%)
At close: May 17, 2024, 4:00 PM
3.070
+0.060 (1.99%)
After-hours: May 17, 2024, 4:34 PM EDT
Century Therapeutics Revenue
Century Therapeutics had revenue of $1.37M in the twelve months ending March 31, 2024, down -76.63% year-over-year. Revenue in the quarter ending March 31, 2024 was $855.00K, a -50.29% decrease year-over-year. In the year 2023, Century Therapeutics had annual revenue of $2.24M, a decrease of -57.01%.
Revenue (ttm)
$1.37M
Revenue Growth
-76.63%
P/S Ratio
183.84
Revenue / Employee
$9,013
Employees
152
Market Cap
251.86M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
Dec 31, 2022 | 5.20M | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIPSC News
- 9 days ago - Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 25 days ago - Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit - GlobeNewsWire
- 5 weeks ago - Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics - GlobeNewsWire
- 5 weeks ago - Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 2 months ago - Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 2 months ago - Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 3 months ago - Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewsWire